264 related articles for article (PubMed ID: 18183502)
41. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.
Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A
Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689
[TBL] [Abstract][Full Text] [Related]
42. Decision-tree approach to the immunophenotype-based prognosis of the B-cell chronic lymphocytic leukemia.
Masić N; Gagro A; Rabatić S; Sabioncello A; Dasić G; Jaksić B; Vitale B
Am J Hematol; 1998 Oct; 59(2):143-8. PubMed ID: 9766799
[TBL] [Abstract][Full Text] [Related]
43. [Evolution of chronic lymphocytic leukemia: predictive value of immunophenotype, soluble CD23 and morphology].
Sarmientó MA; Palacios MF; Scolnik MP; Ramírez FR; Stanganelli C; Cabrera J; Chena CP; Arrossagaray G; Slavutsky IR; Bengió RM
Medicina (B Aires); 2002; 62(4):305-12. PubMed ID: 12325485
[TBL] [Abstract][Full Text] [Related]
44. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.
Hubmann R; Düchler M; Schnabl S; Hilgarth M; Demirtas D; Mitteregger D; Hölbl A; Vanura K; Le T; Look T; Schwarzmeier JD; Valent P; Jäger U; Shehata M
Br J Haematol; 2010 Mar; 148(6):868-78. PubMed ID: 19995395
[TBL] [Abstract][Full Text] [Related]
45. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
Almerigogna F; Biagiotti R; Giudizi MG; Alessi A; Ricci M; Bosi A; Romagnani S
Ric Clin Lab; 1989; 19(2):129-38. PubMed ID: 2528201
[TBL] [Abstract][Full Text] [Related]
46. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
[TBL] [Abstract][Full Text] [Related]
47. [Chronic lymphocytic leukaemia presenting with specific cutaneous infiltrates in the absence of lymphocytosis: Two cases].
Vonarx M; Carpentier O; Cazin B; Bouchindhomme B; Delaporte E
Ann Dermatol Venereol; 2012 Oct; 139(10):641-6. PubMed ID: 23122378
[TBL] [Abstract][Full Text] [Related]
48. The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.
Bumbea H; Vladareanu AM; Vintilescu A; Radesi S; Ciufu C; Onisai M; Baluta C; Begu M; Dobrea C; Arama V; Streinu-Cercel A; Arama S
J Med Life; 2011 Aug; 4(3):256-63. PubMed ID: 22567048
[TBL] [Abstract][Full Text] [Related]
49. CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.
Bund D; Mayr C; Kofler DM; Hallek M; Wendtner CM
Exp Hematol; 2007 Jun; 35(6):920-30. PubMed ID: 17533046
[TBL] [Abstract][Full Text] [Related]
50. Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: implications for prognosis.
Molica S; Dattilo A; Mannella A; Levato D; Levato L
Leuk Res; 1995 Aug; 19(8):573-80. PubMed ID: 7658704
[TBL] [Abstract][Full Text] [Related]
51. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
52. [Characteristics and clinical significance of immunophenotype in chronic lymphocytic leukemia].
Kuang WY; Zhang GS; Xiao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):662-6. PubMed ID: 16114552
[TBL] [Abstract][Full Text] [Related]
53. Chronic lymphocytic leukaemia: a review of the immuno-architecture.
Rosati S; Kluin PM
Curr Top Microbiol Immunol; 2005; 294():91-107. PubMed ID: 16323429
[TBL] [Abstract][Full Text] [Related]
54. Regulation of CD23 isoforms on B-chronic lymphocytic leukemia.
Goller ME; Kneitz C; Mehringer C; Müller K; Jelley-Gibbs DM; Gosselin EJ; Wilhelm M; Tony HP
Leuk Res; 2002 Sep; 26(9):795-802. PubMed ID: 12127553
[TBL] [Abstract][Full Text] [Related]
55. Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia.
Habib LK; Finn WG
Cytometry B Clin Cytom; 2006 May; 70(3):124-35. PubMed ID: 16498670
[TBL] [Abstract][Full Text] [Related]
56. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
[TBL] [Abstract][Full Text] [Related]
57. Chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
[TBL] [Abstract][Full Text] [Related]
58. [A benign form of chronic lympholeukemia].
Iakhnina EI; Nikitin EA; Astsaturov IA; Varlamova EIu; Kobzev IuN; Kovaleva LG; Kremenetskaia AM; Kulikov SM; Melikian AL; Pivnik AV; Samoĭlova RS; Vorob'ev AI
Ter Arkh; 1997; 69(7):11-7. PubMed ID: 9424751
[TBL] [Abstract][Full Text] [Related]
59. Flow cytochemical analysis of peripheral lymphocytes in chronic B-lymphocytic leukemia. Prognostic role of the blast count determined by the H*1 system and its correlation with morphologic features.
Lanza F; Moretti S; Latorraca A; Scapoli G; Rigolin F; Castoldi G
Leuk Res; 1992; 16(6-7):639-46. PubMed ID: 1635382
[TBL] [Abstract][Full Text] [Related]
60. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
